Ethanol administration inhibits hepatic protein and glycoprotein secretion. Previous studies have shown that the metabolism of ethanol is required for this effect. Experiments were designed to determine whether acetaldehyde, the first metabolite of ethanol oxidation, mediated the ethanol-induced sec
Ethanol-induced inhibition of ventricular protein synthesis in vivo and the possible role of acetaldehyde
✍ Scribed by Dr Tahir Siddiq; Peter J. Richardson; William D. Mitchell; Julian Teare; Dr Victor R. Preedy
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 805 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0263-6484
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We have determined the extent to which acute ethanol administration perturbs the synthesis of ventricular contractile and non‐contractile proteins in vivo. Male Wistar rats were treated with a standard dose of ethanol (75 mmol kg^−1^ body weight; i.p.). Controls were treated with isovolumetric amounts of saline (0·15 mol 1^−1^ NaCl). Two metabolic inhibitors of ethanol metabolism were also used namely 4‐methylpyrazole (alcohol dehydrogenase inhibitor) and cyanamide (acetaldehyde dehydrogenase inhibitor) which in ethanol‐dosed rats have been shown to either decrease or increase acetaldehyde formation, respectively. After 2·5 h, fractional rates of protein synthesis (i.e. the percentage of tissue protein renewed each day) were measured with a large (i.e. ‘flooding’) dose of L‐[4‐^3^H]phenylalanine (150 μmol (100 g)^−1^ body weight into a lateral vein). This dose of phenylalanine effectively floods all endogenous free amino acid pools so that the specific radioactivity of the free amino acid at the site of protein synthesis (i.e. the amino acyl tRNA) is reflected by the specific radioactivity of the free amino acid in acid‐soluble portions of cardiac homogenates. The results showed that ethanol alone and ethanol plus 4‐methylpyrazole decreased the fractional rates of mixed, myofibrillar (contractile) and sarcoplasmic (non‐contractile) protein synthesis to the same extent (by approx. 25 per cent). Profound inhibition (i.e. 80 per cent) in the fractional rates of mixed, myofibrillar and sarcoplasmic protein synthesis occurred when cyanamide was used to increase acetaldehyde formation. There was also a significant decrease in cardiac DNA content. The results suggest that acute ethanol‐induced cardiac injury in the rat may be mediated by both acetaldehyde and ethanol.
📜 SIMILAR VOLUMES
Intravenous administration of high doses of tetracycline may produce severe microvesicular steatosis of the liver in man. A similar disease is observed after ingestion of drugs which inhibit hepatic mitochondrial fatty acid @-oxidation and in subjects with various inborn defects in this metabolic pa
## Abstract dd(+)‐Galactosamine is a well‐known experimental hepatotoxin. The present study was conducted to determine the protective role of a 43‐kD protein isolated from the leaves of the herb __Cajanus indicus__ L against dd(+)‐galactosamine (GalN) induced liver damage in mice. Both preventive a
Alanine is a powerful stimulator of hepatic protein synthesis whose mechanism of action has not yet been ascertained. The present work aimed to elucidate whether rate changes in ion fluxes accompanying the transport of this amino acid could play a role in the stimulation of protein synthesis. In per
Activator protein-1 (AP1) regulates the promoter activity of a large number of genes associated with developmental, proliferative, inflammatory, and homeostatic processes in human connective tissue cells. Some of these genes (e.g., cyclooxygenase-2) are regulated by the protein kinase C (PKC) inhibi
## Abstract Protein kinase C (PKC) and extracellular signal‐regulated kinase (ERK) have been implicated in the effects of regulatory peptides on proliferation. We studied how ERK was activated by PKC following regulatory peptide or phorbol ester stimulation and we also investigated the effect of ER